Labcyte Introduces New Acoustic Sample Management Solution

New Tube-Compatible Acoustic Liquid Handler and Automation Platform Set New Standard for High-Throughput Screening February 05, 2018 SAN DIEGO and SAN JOSE, CA Labcyte Inc. today launched the Access™ Dual-Robot System (DRS) and the Echo® 655T Liquid Handler, key components of a new acoustic sample management solution that will support the next generation of pharmaceutical drug discovery as... Read more

SCIEX Announces Co-Marketing Agreement with IROA Technologies LLC to Improve Metabolite Identification & Quantitation in Complex Samples for Untargeted Metabolomics

SCIEX and IROA Technologies LLC to Offer Complete Solution for Next Generation Metabolomics, to Allow Unambiguous Identification and Quantitation of Metabolites in a sample February 05, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced a co-marketing agreement with IROA Technologies LLC, a reagents and kits company specializing in metabolomics analyses. This... Read more

SCIEX Sponsored Award Recognizes Current and Breakthrough Research in the Field of Electro-Driven Separations

2018 SCIEX Microscale Separations, Innovations Medal and Award will be Presented to Dr. Amy E. Herr, Lester John & Lynne Dewar Lloyd Distinguished Professor of Bioengineering at the University of California, Berkeley at MSB 2018, Rio de Janeiro February 05, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, has announced... Read more

Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

Cambridge, United Kingdom – 25 January 2018 –Congenica, a global provider of clinical genomics interpretation software, today announced the appointment of its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in Cambridge, UK, Dr Atkins also joins Congenica’s Board of Directors. Dr Atkins has over 25 years’ experience as a global... Read more

Hitachi High-Tech Science Launches “EMA” Thermal Analysis Software

-Streamlines Analysis by Simplifying the Setting of Optimal Measurement Conditions- Tokyo, Japan, February 1, 2018—Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced that Hitachi High-Tech Science Corporation (Hitachi High-Tech Science), a Hitachi High-Tech wholly owned subsidiary engaged in manufacturing and sales of analysis and measuring instruments, has developed the “EMA” thermal analysis software (EMA). EMA... Read more

Shimadzu has released the Shimadzu GC Driver for Chromeleon™ 7.2

February 1, 2018 Control Nexis GC-2030 and HS-20/HS-10 Using Chromeleon 7.2 Control Shimadzu Nexis GC-2030 and HS-20/HS-10 Headspace sampler. Now Thermo Scientific™ Chromeleon™ 7.2 Chromatography Data System (hereinafter called Chromeleon) Software can control the Nexis GC-2030 and HS-20/HS-10 Headspace sampler with the driver software. Shimadzu GC-2030 and HS-20/HS-10 instrument parameters can be set seamlessly via... Read more

Neogen releases easiest dairy antibiotic tests

CONTACT: Nate Banner, Neogen Corporation, 517/372-9200 LANSING, Mich., Feb. 1, 2018 — Neogen Corporation (NASDAQ: NEOG) today announced that it has released BetaStar® Advanced — the easiest method to test for antibiotics in milk. BetaStar Advanced has been reviewed by the FDA, approved for use by the National Conference on Interstate Milk Shipments (NCIMS), and validated by the AOAC... Read more

Harvard Bioscience Completes Acquisition of Data Sciences International

HOLLISTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International, Inc. (“DSI”). The aggregate consideration payable by the Company in... Read more

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

New system launch planned for second half of 2018 with two CE-IVD molecular diagnostics, U.S. launch planned for 2019 and broad pipeline in development Germantown, Maryland, and Hilden, Germany, January 31, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing... Read more

QIAGEN reports results for fourth quarter and full-year 2017, announces STAT-Dx acquisition and new $200 million share repurchase

Solid Q4 results as QIAGEN achieves full-year 2017 targets: Q4 2017: Net sales $396.9 million ( 8% actual, 5% CER); adjusted net sales rise 6% CER excluding portfolio changes vs. 5-6% CER guidance  Q4 2017: EPS -$0.18 including impact of predominantly non-cash U.S. tax reform charge; adjusted EPS $0.43 ($0.43 CER) vs. ~$0.41-42 CER guidance... Read more